Loading company details...
Beta
Latest Form 4 (Sep 29, 2026): Steven B. Binder (Director): Sale of 39,051 shares, $128.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 29, 2026 | Steven B. Binder | Sale | 39,051 | $128.5K |
| Sep 15, 2026 | Steven B. Binder | Sale | 33,558 | $127.9K |
| Aug 11, 2026 | Steven B. Binder | Sale | 39,051 | $158.5K |
| Jul 18, 2026 | Christopher B. Prentiss, Chief Financial Officer | Tax Withholding | 11,572 | $47.3K |
| Jul 18, 2026 | Dominic Marasco, Pres, Endocrine Business Unit | Tax Withholding | 3,623 | $14.8K |
| Jul 18, 2026 | Stuart A. Tross, Chief People & Workpl Officer | Exercise/Conversion | 93,790 | n/a |
| Jul 18, 2026 | Michael Castagna, Chief Executive Officer | Exercise/Conversion | 350,260 | n/a |
| Jul 18, 2026 | Sanjay R. Singh, EVP Technical Operations | Exercise/Conversion | 70,550 | n/a |
| Jul 18, 2026 | David Thomson, EVP Genl Counsel & Secretary | Exercise/Conversion | 93,790 | n/a |
| Jul 18, 2026 | Steven B. Binder | Exercise/Conversion | 93,790 | n/a |